Monozyme India
No trades in 1Y
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of -24.5% over last 3 years.
- Company has high debtors of 50,127 days.
- Working capital days have increased from 15,794 days to 46,842 days
Growth Rate
Annual windows: The latest annual results are more than two years old, so no annual growth is shown.
Trailing twelve months: No quarterly results are reported.
Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.
Profit & Loss
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 |
|---|---|---|---|
| Sales | 10.55 | 4.96 | 0.03 |
| Expenses | 9.63 | 5.62 | 1.95 |
| Operating Profit | 0.92 | −0.66 | −1.92 |
| OPM % | 8.72% | −13.31% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| Other Income | 0.05 | 0.06 | 2.22 |
| Interest | 0.38 | 0.49 | 0.37 |
| Depreciation | 0.08 | 0.13 | 0.1 |
| PBT | 0.51 | −1.22 | −0.17 |
| Tax % | 35.29% | 7.38% | 0% |
| Net Profit | 0.33 | −1.31 | −0.17 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 |
|---|---|---|---|
| Equity Capital | 3.12 | 3.12 | 3.12 |
| Reserves | −0.23 | −1.54 | −1.71 |
| Borrowings | 5.38 | 4.93 | 2.72 |
| Other Liabilities | 2.96 | 1.49 | 0.72 |
| Total Liabilities | 11.23 | 8 | 4.85 |
| Fixed Assets | 0.71 | 0.59 | 0.4 |
| CWIP | 1.34 | 1.34 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 9.18 | 6.07 | 4.45 |
| Total Assets | 11.23 | 8 | 4.85 |
Cash Flow
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 |
|---|---|---|---|
| Operating | −1.35 | — | — |
| Investing | −1.02 | — | — |
| Financing | 2.8 | — | — |
| Net Cash Flow | 0.43 | — | — |
| Free Cash Flow | −2.41 | — | — |
| CFO/OP | −127 | — | — |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 |
|---|---|---|---|
| Debtor Days | 190 | 330 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| Inventory Days | 155 | 140 | 0 |
| Days Payable | 158 | 52.76 | — |
| Cash Conversion Cycle | 187 | 418 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| Working Capital Days | 192 | 347 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| ROCE % | — | −9.88% | −5.08% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Monozyme insights
29 extracted metrics across FY06–FY26.
Documents
- 22 Jan 2026
- 22 Jan 2026
Frequently Asked Questions about Monozyme India
What does Monozyme India Ltd do?
Where is Monozyme India Ltd (522199) listed?
Which sector does Monozyme India Ltd belong to?
Company Information
Monozyme India Ltd is engaged in Healthcare/Hospitals business.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/522199.md for Monozyme India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.